Last updated on August 2018

Treatment of Atopic Dermatitis by a Full Body Blue Light Device


Brief description of study

Multicentric, placebocontrolled, doubleblinded, threearmed, prospective, randomized controlled trial.150 patients diagnosed with atopic dermatitis will be randomized to arm 1 (irradiation for 30min at 415nm wavelength), arm 2 (irradiation for 30min at 450nm wavelength), and arm 3 (irradiation for 30min at lowdose (placebo)). Irradiation will be scheduled 3 times a week for 8 weeks. Patients will be followed up for four weeks after the last irradiation.

Clinical Study Identifier: NCT03085303

Contact Investigators or Research Sites near you

Start Over

Michael Schoen, Prof

University Hospital Goettingen
Goettingen, Germany

Wolfgang Pfuetzner, Prof

University Hospital Marburg
Marburg, Germany

Hans-Joachim Laubach, Dr

University Hospital Geneva
Geneva, Switzerland

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.